Total Payments
$152,067
2024 Payments
$37,475
Companies
76
Transactions
1,547
Medicare Patients
817
Medicare Billing
$80,050
Payment Breakdown by Category
Other$117,153 (77.0%)
Food & Beverage$26,076 (17.1%)
Travel$6,069 (4.0%)
Consulting$2,440 (1.6%)
Education$329.80 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,153 | 40 | 77.0% |
| Food and Beverage | $26,076 | 1,482 | 17.1% |
| Travel and Lodging | $6,069 | 12 | 4.0% |
| Consulting Fee | $2,440 | 1 | 1.6% |
| Education | $329.80 | 12 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $114,926 | 234 | $0 (2024) |
| Gilead Sciences, Inc. | $18,891 | 212 | $0 (2024) |
| ABBVIE INC. | $2,505 | 110 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,502 | 91 | $0 (2024) |
| Janssen Biotech, Inc. | $1,315 | 106 | $0 (2023) |
| Novo Nordisk Inc | $1,136 | 74 | $0 (2024) |
| PFIZER INC. | $828.81 | 78 | $0 (2024) |
| EMD Serono, Inc. | $755.52 | 44 | $0 (2024) |
| Allergan, Inc. | $690.17 | 62 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $644.37 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,475 | 197 | ViiV Healthcare Company ($22,297) |
| 2023 | $61,710 | 193 | ViiV Healthcare Company ($58,727) |
| 2022 | $26,068 | 207 | ViiV Healthcare Company ($20,839) |
| 2021 | $15,633 | 249 | ViiV Healthcare Company ($12,014) |
| 2020 | $1,934 | 132 | Gilead Sciences, Inc. ($388.18) |
| 2019 | $2,799 | 191 | Gilead Sciences, Inc. ($450.04) |
| 2018 | $2,721 | 188 | Gilead Sciences, Inc. ($320.90) |
| 2017 | $3,727 | 190 | AbbVie, Inc. ($1,213) |
All Payment Transactions
1,547 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: HIV | ||||||
| 12/30/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: HIV | ||||||
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.44 | General |
| 12/19/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: HIV | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $30.41 | General |
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.25 | General |
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Insomnia | ||||||
| 12/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: HIV | ||||||
| 12/04/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: HIV | ||||||
| 12/03/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: HIV | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ADHD | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Obesity | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Obesity | ||||||
| 11/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.19 | General |
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 179 | 307 | $62,722 | $19,745 |
| 2022 | 4 | 185 | 304 | $63,671 | $20,545 |
| 2021 | 5 | 223 | 325 | $70,137 | $23,146 |
| 2020 | 5 | 230 | 311 | $67,254 | $16,614 |
Total Patients
817
Total Services
1,247
Medicare Billing
$80,050
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 218 | $37,507 | $11,093 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 28 | $9,505 | $3,308 | 34.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $6,345 | $3,059 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 37 | $9,365 | $2,284 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 182 | $31,313 | $9,331 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 84 | $21,260 | $6,157 | 29.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $6,345 | $3,128 | 49.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $4,753 | $1,929 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 148 | $25,463 | $8,110 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 99 | $25,057 | $7,020 | 28.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 36 | 38 | $12,900 | $4,719 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 22 | 22 | $5,816 | $2,928 | 50.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 18 | 18 | $900.00 | $369.54 | 41.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 100 | $25,310 | $5,679 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 95 | 144 | $24,775 | $5,270 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $7,403 | $3,273 | 44.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 27 | $9,166 | $2,157 | 23.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $600.00 | $234.96 | 39.2% |
About Dr. Scott Parry, D.O
Dr. Scott Parry, D.O is a Internal Medicine healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306860101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Parry, D.O has received a total of $152,067 in payments from pharmaceutical and medical device companies, with $37,475 received in 2024. These payments were reported across 1,547 transactions from 76 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,153).
As a Medicare-enrolled provider, Parry has provided services to 817 Medicare beneficiaries, totaling 1,247 services with total Medicare billing of $80,050. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Atlanta, GA
- Active Since 07/26/2006
- Last Updated 10/25/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306860101
Products in Payments
- DOVATO (Drug) $111,845
- Descovy (Drug) $14,265
- Androgel (Drug) $1,244
- VRAYLAR (Drug) $1,163
- SYMTUZA (Drug) $871.70
- Biktarvy (Drug) $800.00
- PIFELTRO (Drug) $572.07
- CABENUVA (Biological) $545.70
- APRETUDE (Biological) $524.77
- NURTEC ODT (Drug) $513.79
- FARXIGA (Drug) $512.89
- Ozempic (Drug) $507.61
- PREZCOBIX (Drug) $382.66
- ISENTRESS (Drug) $381.78
- SEROSTIM (Biological) $381.24
- REXULTI (Drug) $379.17
- UBRELVY (Drug) $369.73
- VYVANSE (Drug) $368.03
- CHANTIX (Drug) $350.51
- EGRIFTA (Drug) $328.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atlanta
Dr. Nitin Gupta, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Zandraetta Tims-Cook, Md, Mph, MD, MPH
Internal Medicine — Payments: $648,799
Internal Medicine $648,799
Brian Pearlman, Md, MD
Internal Medicine — Payments: $588,483
Internal Medicine $588,483
Tracey Henry
Internal Medicine — Payments: $304,663
Internal Medicine $304,663
Michael Lloyd, Md, MD
Internal Medicine — Payments: $276,236
Internal Medicine $276,236
Mr. Robert Springer, M.d, M.D
Internal Medicine — Payments: $243,195
Internal Medicine $243,195